2017 Subject Index
15q deletion...................................................................... 380
17-hydroxylase deficiency............................................ 163
46,XY disorder of sex development............................ 163
46,XY disorder of sex development............................... 85
Acrodysostosis................................................................. 360
ADAMTS-1......................................................................... 24
Adiponectin...................................................................... 202
Adolescence..................................................................... 237
Adolescent............................................................... 132, 375
Adolescents.............................. 39, 58, 246, 253, 265, 329
Albright hereditary osteodystrophy................................ 74
Alkaline phosphatase....................................................... 63
Amino-terminal propeptide of C-type natriuretic
peptide............................................................................... 308
Anastrozole...................................................................... 168
Anthropometry................................................................ 329
Anti-glutamic acid decarboxylase............................... 388
Anti-Müllerian hormone receptor mutation............... 179
Anti-Müllerian hormone receptor resistance.............. 179
Apoplexy.......................................................................... 265
Biomarker......................................................................... 308
Blood glucose................................................................... 156
Body mass index.................................................... 111, 337
Bone marker.................................................................... 106
Bone mineral density...................................................... 237
Bone turnover.................................................................. 237
Brachydactyly................................................................. 360
BRAF mutation............................................................... 185
C-type natriuretic peptide.............................................. 308
Cardiomyopathy............................................................... 52
Carotid intima-media thickness................................... 144
Cerebral cavernous malformation............................... 355
Characteristics.................................................................... 58
Child.................................................................................. 118
Child obesity.................................................................... 124
Childhood............................................................ 31, 91, 144
Childhood obesity................................................................ 8
Children......... 39, 58, 132, 185, 246, 288, 329, 337, 344
Children and adolescent....................................... 111, 323
Cinacalcet......................................................................... 172
Clinical decision making................................................ 208
Clinical presentation....................................................... 194
Complication................................................................... 293
Congenital........................................................................ 278
Congenital adrenal hyperplasia.................................. 1, 85
Congenital hyperinsulinism........................................... 194
Congenital hypothyroidism........................................... 106
Cornelia de Lange syndrome........................................ 366
Cortisol..................................................................... 237, 344
Cut-offs............................................................................... 17
Diabetes...................................................................... 52, 388
Diabetes eating problem survey-revised..................... 323
Diabetes insipidus............................................................ 283
Diabetes mellitus............................................................. 283
Diabetic ketoacidosis............................................. 118, 283
Diagnose........................................................................... 163
Disordered eating attitude.............................................. 237
Distributed eating behaviors.......................................... 323
Duplication 4q................................................................. 380
Dyslipidemia.................................................................... 144
Ectopic ossification........................................................... 74
Endocrine diseases............................................................ 48
Euthyroid.......................................................................... 337
Fat mass............................................................................ 124
Fetuin-a............................................................................. 293
FGFR1 mutations.............................................................. 95
Fine-needle aspiration biopsy....................................... 222
Frame size......................................................................... 329
Frequency........................................................................... 58
Frozen section.................................................................. 222
GAMLSS method.............................................................. 39
GCK-MODY..................................................................... 246
Gene mutation................................................................. 194
Gene polymorphisms...................................................... 138
Genetic syndromes............................................................ 91
Genetic testing.................................................................... 80
Genotype.......................................................................... 246
Glucokinase...................................................................... 355
Glucokinase-Maturity-Onset Diabetes of the
Young................................................................................ 246
Glutathione S-transferase T1 and M1......................... 138
Glycemic control............................................................. 253
Glycemic variability........................................................ 202
GNAS gene.......................................................................... 74
Growth...................................................................... 208, 308
Growth hormone............................................................. 366
Growth hormone deficiency.......................................... 208
Growth hormone receptor.............................................. 380
Growth hormone therapy..................................... 208, 380
Growth percentiles........................................................... 329
Gsa activity......................................................................... 74
Headache......................................................................... 265
Heart-type fatty acid binding protein.......................... 118
Height.................................................................................. 39
Hereditary vitamin D-resistant rickets......................... 172
High-fat diet..................................................................... 300
Hirsutism............................................................................... 1
HSD3B2 gene..................................................................... 70
HSD3b gene........................................................................ 85
Hypercalcemia................................................................ 315
Hyperglycemia................................................................ 355
Hyperinsulinism............................................................... 375
Hyperparathyroidism..................................................... 315
Hyperprolactinemia........................................................ 350
Hypertension.................................................................... 344
Hypertriglyceridemia........................................................ 52
Hypoglycemia................................................................. 375
Hypogonadotropic hypogonadism................................ 95
Hyponatremia................................................................. 288
Hypophosphatasia......................................................... 229
Hypothyroidism..................................................... 278, 337
Idiopathic infantile hypercalcemia.............................. 315
Inactivating parathyroid hormone/parathyroid
hormone related protein signalling disorder................ 360
Initial doses...................................................................... 132
INSR................................................................................... 371
Insulin resistance...................................................... 31, 371
Insulin-like growth factor-I............................................ 208
Insulinoma....................................................................... 375
Intellectual disability...................................................... 355
Interleukin-6..................................................................... 202
Intrauterine growth......................................................... 300
Irisin................................................................................... 124
Kallmann syndrome......................................................... 95
Kisspeptin......................................................................... 101
Large-cell calcifying Sertoli cell tumor........................ 168
Limbic encephalitis......................................................... 388
Lipodystrophy.................................................................... 52
Magnetic resonance imaging........................................ 265
Malignancy-related hypercalcemia............................. 315
Maturity-onset diabetes................................................. 355
Melanocortin-4 receptor................................................ 216
Menarcheal age............................................................... 156
Metabolic syndrome....................................................... 202
Multiple endocrine neoplasia 1..................................... 375
Mutation........................................................................... 216
Neck circumference.......................................................... 17
Neonatal diabetes.................................................. 260, 274
Neonate............................................................................. 194
Neurokinin B.................................................................... 101
NIPBL................................................................................ 366
Non-alcoholic fatty liver disease.................................. 293
Non-classical congenital adrenal hyperplasia................ 1
Noncommunicable disease........................................... 156
Nonsense mutation......................................................... 260
Nutrient transport............................................................ 300
Nutritional rickets.............................................................. 63
Obesity........... 17, 31, 111, 216, 237, 300, 308, 337, 344
Otitis media with effusion................................................ 48
Ovarian cyst....................................................................... 58
Overweight............................................................... 111, 308
Oxoglutarate dehydrogenase........................................ 355
Oxytocin........................................................................... 124
Pancreatic agenesis......................................................... 274
Panhypopituitarism........................................................ 265
Papillary carcinoma........................................................ 222
Papillary thyroid cancer................................................. 185
Parents............................................................................... 111
Pathophysiology.............................................................. 344
Pediatric............................................................................ 337
Pediatric thyroid cancer................................................. 185
Pediatrics........................................................................... 315
Perceived expressed emotion........................................ 253
Percentile............................................................................. 39
Percentiles........................................................................... 17
Peutz-Jeghers syndrome................................................. 168
Phenotype......................................................................... 246
Phosphodiesterase 4D.................................................... 360
Pituitary abscess.............................................................. 265
Pituitary adenoma.......................................................... 265
Placenta............................................................................ 300
Polycystic ovary syndrome............................................. 24
Potassium......................................................................... 163
Precocious puberty.......................................................... 101
Prepubertal gynecomastia............................................. 168
Preschool children.............................................................. 17
Prolactin............................................................................ 350
Proprotein convertase 1/3 deficiency.......................... 283
Pseudohypoparathyroidism Ia....................................... 74
PTF1A gene...................................................................... 274
Puberty.............................................................................. 185
Rabson-Mendenhall syndrome ................................... 371
Reduced penetrance......................................................... 95
Regular insulin................................................................. 132
Reproductive age............................................................ 156
Rickets............................................................................... 150
Secondary hyperparathyroidism.................................. 172
Short stature........................................................ 74, 91, 380
Skeletal dysplasia............................................................ 360
Small for gestational age............................................... 366
Solid pseudopapillary tumor......................................... 375
Splicing.............................................................................. 260
Steroid 3b-HSD2 deficiency............................................ 70
Stoss therapy............................................................. 63, 150
Stress.................................................................................. 237
Subclinical hypothyroidism.................................. 144, 350
Syndrome of inappropriate antidiuretic hormone
secretion............................................................................ 288
Testicular adrenal rest tumor........................................... 85
Thyroid hormones............................................................... 8
Thyroid nodule................................................................ 222
Thyroid stimulating hormone.............................. 337, 350
Thyroidectomy................................................................ 222
Thyrotropin deficiency................................................... 278
Thyroxin........................................................................... 106
Tight junctions................................................................... 31
Tolvaptan......................................................................... 288
Treatment......................................................................... 283
Turkish children............................................................... 229
Tympanometry.................................................................. 48
Type 1 diabetes mellitus............ 132, 138, 253, 293, 323
Undescended testis.......................................................... 179
Uniparental isodisomy...................................................... 70
Versican............................................................................... 24
Virilization............................................................................. 1
Vitamin D............................................................................ 63
Vitamin D deficiency...................................................... 150
Waist-height ratio................................................................. 8
Weight.................................................................................. 39
WFS1 gene.......................................................................... 80
Whole-exome sequencing.............................................. 366
Wolfram syndrome........................................................... 80
Wrist circumferences...................................................... 329
Zonulin......................................................................... 31
